XML 24 R11.htm IDEA: XBRL DOCUMENT v3.24.4
Revenue
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]    
Revenue

4. Revenue

 

We generate revenue primarily through the sales of our licensed products Ameluz® and RhodoLED® Lamps. Revenue from the sales of our lamps are relatively insignificant compared with the revenues generated through our sales of Ameluz®.

 

Related party revenue relates to an agreement with Biofrontera Bioscience for BF-RhodoLED® leasing and installation service associated with the clinical lamps, which, due to the Second A&R Ameluz LSA is no longer effective as of September 30, 2024. Refer to Note 11, Related Party Transactions.

 

An analysis of the changes in product revenue allowances and reserves is summarized as follows:

 

(in thousands):  Returns  

Co-pay

assistance program

  

Prompt

pay discounts

  

Government

and payor rebates

   Total 
Balance at December 31, 2022  $48   $9   $5   $20   $82 
Provision related to current period sales   4    156    3    266    429 
Credit or payments made during the period   -    (145)   (2)   (231)   (378)
Balance at September 30, 2023  $52   $20   $6   $55   $133 
                          
Balance at December 31, 2023  $52   $-   $6   $54   $112 
Provision related to current period sales   32    -    -    157    189 
Credit or payments made during the period   (6)   -    (6)   (167)   (179)
Balance at September 30, 2024  $78    -    -    44    122 

 

5. Revenue

 

We generate revenue primarily through the sales of our licensed products Ameluz®, BF-RhodoLED® lamps and Xepi®. Revenue from the sales of our BF-RhodoLED® lamp and Xepi® are relatively insignificant compared with the revenues generated through our sales of Ameluz®.

 

Related party revenue relates to an agreement with Biofrontera Bioscience for BF-RhodoLED® leasing and installation service. Refer to Note 17. Related Party Transactions.

 

An analysis of the changes in product revenue allowances and reserves is summarized as follows:

 Schedule of Revenue Allowance and Accrual Activities

                     
       Co-pay   Prompt   Government     
       assistance   pay   and payor     
(in thousands):  Returns   program   discounts   rebates   Total 
Balance at December 31, 2021  $43   $101   $48   $54   $246 
Provision related to current period sales   10    574    19    210    813 
Credit or payments made during the period   (5)   (666)   (62)   (244)   (977)
Balance at December 31, 2022  $48   $9   $5   $20   $82 
Provision related to current period sales   4    156    3    344    507 
Credit or payments made during the period   -    (165)   (2)   (310)   (477)
Balance at December 31, 2023  $52    -    6    54    112